Clinical Trial Update: Fludarabine and 400 CGY Total Body Irradiation for Recipients of HLA-Matched or Mis-Matched Family or Unrelated Donor Hematopoietic Stem Cell Transplants Who Have Rejected Their First Allogeneic Stem Cell Transplant [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial evaluating a conditioning regimen of fludarabine plus total body irradiation for patients who have graft failure after an initi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft Failure

Drugs mentioned

• Fludarabine (Fludarabine)

Snippet

Sponsor: Colorado Blood Cancer Institute | Conditions: Graft Failure | Phase 2 | Status: UNKNOWN